Chromatic pupillometry dissects function of the three different light-sensitive retinal cell populations in RPE65 deficiency

Investigative Ophthalmology and Visual Science

Volumn 53, Issue 9, 2012, Pages 5641-5652

  Lorenz, Birgit ^a   Strohmayr, Elisabeth ^a   Zahn, Steffen ^a   Friedburg, Christoph ^a   Kramer, Martin ^a   Preising, Markus ^a   Stieger, Knut ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; COLOR BLINDNESS; CONTROLLED STUDY; GENE; GENE MUTATION; HUMAN; PHOTORECEPTOR; PRESCHOOL CHILD; PRIORITY JOURNAL; PUPILLOMETRY; RETINA GANGLION CELL; RPE65 GENE; TEST RETEST RELIABILITY; VISUAL ACUITY; VISUAL FIELD; VISUAL STIMULATION; CLINICAL TRIAL; COLOR VISION DEFECT; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; FEMALE; GENETICS; INSTRUMENTATION; MALE; METHODOLOGY; PATHOPHYSIOLOGY; PERIMETRY; PHENOTYPE; PHOTOSTIMULATION; PHYSIOLOGY; PUPIL REFLEX; REPRODUCIBILITY; RETINA CONE; RETINA ROD; SENSITIVITY AND SPECIFICITY; STANDARD; VISUAL SYSTEM EXAMINATION;

CIS TRANS ISOMERASE; RETINOID ISOMEROHYDROLASE;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CIS-TRANS-ISOMERASES; COLOR VISION DEFECTS; DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL; FEMALE; HUMANS; MALE; PHENOTYPE; PHOTIC STIMULATION; REFLEX, PUPILLARY; REPRODUCIBILITY OF RESULTS; RETINAL CONE PHOTORECEPTOR CELLS; RETINAL GANGLION CELLS; RETINAL ROD PHOTORECEPTOR CELLS; SENSITIVITY AND SPECIFICITY; VISUAL ACUITY; VISUAL FIELD TESTS; YOUNG ADULT;

EID: 84871696752     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.12-9974     Document Type: Article

References (67)

1. Gu SM, Thompson DA, Srikumari CR, et al. Mutations in RPE65 cause autosomal recessive childhood-onset severe retinal dystrophy. Nat Genet. 1997;17:194-197.
2. Lorenz B, Gyurus P, Preising M, et al. Early-onset severe rodcone dystrophy in young children with RPE65 mutations. Invest Ophthalmol Vis Sci. 2000;41:2735-2742.
3. Jacobson SG, Aleman TS, Cideciyan AV, et al. Defining the residual vision in Leber congenital amaurosis caused by RPE65 mutations. Invest Ophthalmol Vis Sci. 2009;50:2368-2375.
4. Lorenz B, Wabbels B, Wegscheider E, Hamel CP, Drexler W, Preising MN. Lack of fundus autofluorescence to 488 nanometers from childhood on in patients with early-onset severe retinal dystrophy associated with mutations in RPE65. Ophthalmology. 2004;111:1585-1594.
5. Lorenz B, Poliakov E, Schambeck M, Friedburg C, Preising MN, Redmond TM. A comprehensive clinical and biochemical functional study of a novel RPE65 hypomorphic mutation. Invest Ophthalmol Vis Sci. 2008;49:5235-5242.
6. Tang PH, Buhusi MC, Ma JX, Crouch RK. RPE65 is present in human green/red cones and promotes photopigment regeneration in an in vitro cone cell model. J Neurosci. 2011;31: 18618-18626.
7. Tang PH, Wheless L, Crouch RK. Regeneration of photopigment is enhanced in mouse cone photoreceptors expressing RPE65 protein. J Neurosci. 2011;31:10403-10411.
8. Znoiko SL, Crouch RK, Moiseyev G, Ma JX. Identification of the RPE65 protein in mammalian cone photoreceptors. Invest Ophthalmol Vis Sci. 2002;43:1604-1609.
9. Jin M, Li S, Moghrabi WN, Sun H, Travis GH. Rpe65 is the retinoid isomerase in bovine retinal pigment epithelium. Cell. 2005;122:449-459.
10. Moiseyev G, Chen Y, Takahashi Y, Wu BX, Ma JX. RPE65 is the isomerohydrolase in the retinoid visual cycle. Proc Natl Acad Sci U S A. 2005;102:12413-12418.
11. Jacobson SG, Aleman TS, Cideciyan AV, et al. Human cone photoreceptor dependence on RPE65 isomerase. Proc Natl Acad Sci U S A. 2007;104:15123-15128.
12. Acland GM, Aguirre GD, Ray J, et al. Gene therapy restores vision in a canine model of childhood blindness. Nat Genet. 2001;28:92-95.
13. Le Meur G, Stieger K, Smith AJ, et al. Restoration of vision in RPE65-deficient Briard dogs using an AAV serotype 4 vector that specifically targets the retinal pigmented epithelium. Gene Ther. 2007;14:292-303.
14. Narfstrom K, Katz ML, Ford M, Redmond TM, Rakoczy E, Bragadottir R. In vivo gene therapy in young and adult RPE65-/-dogs produces long-term visual improvement. J Hered. 2003;94:31-37.
15. Pang JJ, Chang B, Kumar A, et al. Gene therapy restores visiondependent behavior as well as retinal structure and function in a mouse model of RPE65 Leber congenital amaurosis. Mol Ther. 2006;13:565-572.
16. Bainbridge JW, Smith AJ, Barker SS, et al. Effect of gene therapy on visual function in Leber's congenital amaurosis. N Engl J Med. 2008;358:2231-2239.
17. Hauswirth WW, Aleman TS, Kaushal S, et al. Treatment of Leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial. Hum Gene Ther. 2008;19: 979-990.
18. Maguire AM, Simonelli F, Pierce EA, et al. Safety and efficacy of gene transfer for Leber's congenital amaurosis. N Engl J Med. 2008;358:2240-2248.
19. Banin E, Bandah-Rosenfeld D, Obolensky A, et al. Molecular anthropology meets genetic medicine to treat blindness in the North African Jewish population: human gene therapy initiated in Israel. Hum Gene Ther. 2010;21:1749-1757.
20. Cideciyan AV, Hauswirth WW, Aleman TS, et al. Vision 1 year after gene therapy for Leber's congenital amaurosis. N Engl J Med. 2009;361:725-727.
21. Cideciyan AV, Hauswirth WW, Aleman TS, et al. Human RPE65 gene therapy for Leber congenital amaurosis: persistence of early visual improvements and safety at 1 year. Hum Gene Ther. 2009;20:999-1004.
22. Jacobson SG, Cideciyan AV, Ratnakaram R, et al. Gene therapy for Leber congenital amaurosis caused by RPE65 mutations: safety and efficacy in 15 children and adults followed up to 3 years. Arch Ophthalmol. 2012;130:9-24.
23. Maguire AM, High KA, Auricchio A, et al. Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial. Lancet. 2009;374:1597-1605.
24. Simonelli F, Maguire AM, Testa F, et al. Gene therapy for Leber's congenital amaurosis is safe and effective through 1.5 years after vector administration. Mol Ther. 2010;18:643-650.
25. MacLaren RE. An analysis of retinal gene therapy clinical trials. Curr Opin Mol Ther. 2009;11:540-546.
26. Aleman TS, Jacobson SG, Chico JD, et al. Impairment of the transient pupillary light reflex in Rpe65(-/-) mice and humans with Leber congenital amaurosis. Invest Ophthalmol Vis Sci. 2004;45:1259-1271.
27. Roman AJ, Schwartz SB, Aleman TS, et al. Quantifying rod photoreceptor-mediated vision in retinal degenerations: darkadapted thresholds as outcome measures. Exp Eye Res. 2005; 80:259-272.
28. Clarke RJ, Zhang H, Gamlin PD. Characteristics of the pupillary light reflex in the alert rhesus monkey. J Neurophysiol. 2003; 89:3179-3189.
29. Gamlin PD, Clarke RJ. The pupillary light reflex pathway of the primate. J Am Optom Assoc. 1995;66:415-418.
30. Guler AD, Ecker JL, Lall GS, et al. Melanopsin cells are the principal conduits for rod-cone input to non-image-forming vision. Nature. 2008;453:102-105.
31. Loewenfeld IE. The Pupil: Anatomy, Physiology, and Clinical Applications. Ames, Iowa: Iowa State University Press; 1993.
32. Lucas RJ, Douglas RH, Foster RG. Characterization of an ocular photopigment capable of driving pupillary constriction in mice. Nat Neurosci. 2001;4:621-626.
33. Foster RG, Provencio I, Hudson D, Fiske S, De GW, Menaker M. Circadian photoreception in the retinally degenerate mouse (rd/rd). J Comp Physiol A. 1991;169:39-50.
34. Keeler CE. Iris movements in blind mice. Am J Physiol. 1927; 81:107-112.
35. Berson DM, Dunn FA, Takao M. Phototransduction by retinal ganglion cells that set the circadian clock. Science. 2002;295: 1070-1073.
36. Hattar S, Liao HW, Takao M, Berson DM, Yau KW. Melanopsincontaining retinal ganglion cells: architecture, projections, and intrinsic photosensitivity. Science. 2002;295:1065-1070.
37. Hattar S, Lucas RJ, Mrosovsky N, et al. Melanopsin and rodcone photoreceptive systems account for all major accessory visual functions in mice. Nature. 2003;424:76-81.
38. Lucas RJ, Hattar S, Takao M, Berson DM, Foster RG, Yau KW. Diminished pupillary light reflex at high irradiances in melanopsin-knockout mice. Science. 2003;299:245-247.
39. Panda S, Provencio I, Tu DC, et al. Melanopsin is required for non-image-forming photic responses in blind mice. Science. 2003;301:525-527.
40. Fu Y, Liao HW, Do MT, Yau KW. Non-image-forming ocular photoreception in vertebrates. Curr Opin Neurobiol. 2005;15: 415-422.
41. Fu Y, Zhong H, Wang MH, et al. Intrinsically photosensitive retinal ganglion cells detect light with a vitamin A-based photopigment, melanopsin. Proc Natl Acad Sci U S A. 2005; 102:10339-10344.
42. Melyan Z, Tarttelin EE, Bellingham J, Lucas RJ, Hankins MW. Addition of human melanopsin renders mammalian cells photoresponsive. Nature. 2005;433:741-745.
43. Panda S, Nayak SK, Campo B, Walker JR, Hogenesch JB, Jegla T. Illumination of the melanopsin signaling pathway. Science. 2005;307:600-604.
44. Qiu X, Kumbalasiri T, Carlson SM, et al. Induction of photosensitivity by heterologous expression of melanopsin. Nature. 2005;433:745-749.
45. Dacey DM, Liao HW, Peterson BB, et al. Melanopsin-expressing ganglion cells in primate retina signal colour and irradiance and project to the LGN. Nature. 2005;433:749-754.
46. Gamlin PD, McDougal DH, Pokorny J, Smith VC, Yau KW, Dacey DM. Human and macaque pupil responses driven by melanopsin-containing retinal ganglion cells. Vision Res. 2007; 47:946-954.
47. Kardon R, Anderson SC, Damarjian TG, Grace EM, Stone E, Kawasaki A. Chromatic pupil responses: preferential activation of the melanopsin-mediated versus outer photoreceptormediated pupil light reflex. Ophthalmology. 2009;116:1564-1573.
48. Park JC, Moura AL, Raza AS, Rhee DW, Kardon RH, Hood DC. Toward a clinical protocol for assessing rod, cone, and melanopsin contributions to the human pupil response. Invest Ophthalmol Vis Sci. 2011;52:6624-6635.
49. Feigl B, Mattes D, Thomas R, Zele AJ. Intrinsically photosensitive (melanopsin) retinal ganglion cell function in glaucoma. Invest Ophthalmol Vis Sci. 2011;52:4362-4367.
50. Kankipati L, Girkin CA, Gamlin PD. The post-illumination pupil response is reduced in glaucoma patients. Invest Ophthalmol Vis Sci. 2011;52:2287-2292.
51. Feigl B, Zele AJ, Fader SM, et al. The post-illumination pupil response of melanopsin-expressing intrinsically photosensitive retinal ganglion cells in diabetes. Acta Ophthalmol. 2011; 90:e230-e234.
52. McDougal DH, Gamlin PD. The influence of intrinsicallyphotosensitive retinal ganglion cells on the spectral sensitivity and response dynamics of the human pupillary light reflex. Vision Res. 2010;50:72-87.
53. Paunescu K, Wabbels B, Preising MN, Lorenz B. Longitudinal and cross-sectional study of patients with early-onset severe retinal dystrophy associated with RPE65 mutations. Graefes Arch Clin Exp Ophthalmol. 2005;243:417-426.
54. Herbst K, Sander B, Milea D, Lund-Andersen H, Kawasaki A. Test-retest repeatability of the pupil light response to blue and red light stimuli in normal human eyes using a novel pupillometer. Front Neurol. 2011;2:10.
55. Redmond TM, Yu S, Lee E, et al. Rpe65 is necessary for production of 11-cis-vitamin A in the retinal visual cycle. Nat Genet. 1998;20:344-351.
56. Kardon R, Anderson SC, Damarjian TG, Grace EM, Stone E, Kawasaki A. Chromatic pupillometry in patients with retinitis pigmentosa. Ophthalmology. 2011;118:376-381.
57. Znoiko SL, Rohrer B, Lu K, Lohr HR, Crouch RK, Ma JX. Downregulation of cone-specific gene expression and degeneration of cone photoreceptors in the Rpe65-/-mouse at early ages. Invest Ophthalmol Vis Sci. 2005;46:1473-1479.
58. Rohrer B, Lohr HR, Humphries P, Redmond TM, Seeliger MW, Crouch RK. Cone opsin mislocalization in Rpe65-/-mice: a defect that can be corrected by 11-cis retinal. Invest Ophthalmol Vis Sci. 2005;46:3876-3882.
59. Samardzija M, von Lintig J, Tanimoto N, et al. R91W mutation in Rpe65 leads to milder early-onset retinal dystrophy due to the generation of low levels of 11-cis-retinal. Hum Mol Genet. 2008;17:281-292.
60. Tu DC, Owens LA, Anderson L, et al. Inner retinal photoreception independent of the visual retinoid cycle. Proc Natl Acad Sci U S A. 2006;103:10426-10431.
61. Doyle SE, Castrucci AM, McCall M, Provencio I, Menaker M. Nonvisual light responses in the Rpe65 knockout mouse: rod loss restores sensitivity to the melanopsin system. Proc Natl Acad Sci U S A. 2006;103:10432-10437.
62. Kawasaki A, Kardon RH. Intrinsically photosensitive retinal ganglion cells. J Neuroophthalmol. 2007;27:195-204.
63. Kawasaki A, Herbst K, Sander B, Milea D. Selective wavelength pupillometry in Leber hereditary optic neuropathy. Clin Experiment Ophthalmol. 2010;38:322-324.
64. Kankipati L, Girkin CA, Gamlin PD. Post-illumination pupil response in subjects without ocular disease. Invest Ophthalmol Vis Sci. 2010;51:2764-2769.
65. Lall GS, Revell VL, Momiji H, et al. Distinct contributions of rod, cone, and melanopsin photoreceptors to encoding irradiance. Neuron. 2010;66:417-428.
66. Leon L, Crippa SV, Borruat FX, Kawasaki A. Differential effect of long versus short wavelength light exposure on pupillary re-dilation in patients with outer retinal disease. Clin Experiment Ophthalmol. 2012;40:e16-e24.
67. Allen AE, Brown TM, Lucas RJ. A distinct contribution of shortwavelength-sensitive cones to light-evoked activity in the mouse pretectal olivary nucleus. J Neurosci. 2011;31:16833-16843.